Science Letter
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Science Letter
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angelman Syndrome
Gene expression in AS patients analyzed with custom microarray
April 5th, 2005
Gene expression in Angelman syndrome (AS) has been characterized through microarray analysis. AS "is a neurodevelopmental disorder due to a functional deficit, usually a deletion, of the UBE3A gene located in the 15q11-q13 chromosome region," scientists in Kansas City explained. In the journal Genomics, D.C. Bittel and coauthors at the Children's Mercy Hospitals and Clinics presented the results of "the first microarray analysis of gene expression in AS using a custom cDNA microarray to compare expression patterns from lymphoblastoid cell lines from control males and AS subjects with a 15q deletion or uniparental paternal disomy...
Source: Science Letter (2005-04-05)
|
